Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis
Conditions
Interventions
Intervention1: CHARACTERISTIC PARTICULAR-BASED HOMOEOPATHIC PRESCRIPTION: HOMOEOPATHIC MEDICINE IN CENTESIMAL POTENCY SELECTED SOLELY BASED ON CHARACTERISTIC SYMPTOMS OF DRUG WITH CHARACTERISTIC PARTI
Sponsors
NISHTHA BACKER K V
Eligibility
Inclusion criteria
Inclusion criteria: 1.MALE AND FEMALE PATIENTS BETWEEN THE AGES OF 18 AND 60. 2.PATIENTS MEETING THE CASE DEFINITION OF GERD. 3.GERDQ TOOL SCORE MORE THAN OR EQUAL TO 8.
Exclusion criteria
Exclusion criteria: 1.HISTORY OF PREVIOUS GASTROINTESTINAL SURGERY GASTROINTESTINAL HAEMORRHAGE GASTRIC CANCER. 2.PATIENTS WITH ALARM SYMPTOMS OR SEVERE SYSTEMIC ILLNESS. 3.PREGNANT OR LACTATING WOMEN. 4.PATIENTS CURRENTLY ON NSAIDS.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IMPROVEMENT IN GERD SYMPTOMS. SYMPTOMATIC IMPROVEMENT WILL BE ASSESSED USING THE GERD QUESTIONNAIRE (GERDQ). THE GERDQ SCORE WILL BE RECORDED AT BASELINE AND REGULAR FOLLOW UP INTERVALS (EVERY 2 TO 3 WEEKS) THROUGHOUT THE 12 WEEK TREATMENT PERIOD. THE DEGREE OF CHANGE IN GERDQ SCORES FROM BASELINE TO THE END OF THE TREATMENT PERIOD WILL BE USED TO EVALUATE TREATMENT EFFECTIVENESS IN BOTH GROUPS.Timepoint: GERDQ SCORE RECORDED EVERY 2-3 WEEKS THROUGHOUT 12 WEEK TREATMENT PERIOD | — |
Secondary
| Measure | Time frame |
|---|---|
| RECURRENCE OF SYMPTOMS. THE RECURRENCE OF GERD SYMPTOMS AFTER INITIAL IMPROVEMENT WILL BE TRACKED DURING THE 12 WEEK TREATMENT PERIOD. THE DURATION TO RECURRENCE AND FREQUENCY OF RECURRENCE WILL BE RECORDED AND COMPARED BETWEEN THE TWO GROUPS, BASED ON CHANGES IN GERDQ SCORES.Timepoint: GERDQ SCORE RECORDED EVERY 2-3 WEEKS THROUGHOUT 12 WEEK TREATMENT PERIOD | — |
Countries
India
Contacts
Public ContactDR RITHESH B
GOVERNMENT HOMOEOPATHIC MEDICAL COLLEGE KOZHIKODE
Outcome results
None listed